101. [Untitled]
- Author
-
Kelen C. R. Malmegrim, Walther J. van Venrooij, Reinout Raijmakers, Wilma Vree Egberts, Peter Vandenabeele, Xavier Saelens, Geurt Schilders, Lieselotte Vande Walle, and Ger J. M. Pruijn
- Subjects
animal structures ,biology ,Protein subunit ,fungi ,Immunology ,Cleavage (embryo) ,behavioral disciplines and activities ,Exosome ,Jurkat cells ,Molecular biology ,Rheumatology ,immune system diseases ,hemic and lymphatic diseases ,biology.protein ,Immunology and Allergy ,Nuclear protein ,Peptide sequence ,Caspase ,Exosome Multienzyme Ribonuclease Complex - Abstract
Recent studies have implicated the dying cell as a potential reservoir of modified autoantigens that might initiate and drive systemic autoimmunity in susceptible hosts. A number of subunits of the exosome, a complex of 3'→5' exoribonucleases that functions in a variety of cellular processes, are recognized by the so-called anti-PM/Scl autoantibodies, found predominantly in patients suffering from an overlap syndrome of myositis and scleroderma. Here we show that one of these subunits, PM/Scl-75, is cleaved during apoptosis. PM/Scl-75 cleavage is inhibited by several different caspase inhibitors. The analysis of PM/Scl-75 cleavage by recombinant caspase proteins shows that PM/Scl-75 is efficiently cleaved by caspase-1, to a smaller extent by caspase-8, and relatively inefficiently by caspase-3 and caspase-7. Cleavage of the PM/Scl-75 protein occurs in the C-terminal part of the protein at Asp369 (IILD369↓G), and at least a fraction of the resulting N-terminal fragments of PM/Scl-75 remains associated with the exosome. Finally, the implications of PM/Scl-75 cleavage for exosome function and the generation of anti-PM/Scl-75 autoantibodies are discussed.
- Published
- 2007
- Full Text
- View/download PDF